June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Ahmed glaucoma valve FP7 and FP8 in pediatric glaucoma: A randomized clinical trial
Author Affiliations & Notes
  • Bruno Esporcatte
    Glaucoma, Federal University of São Paulo, São Paulo, Brazil
  • Camila Netto
    Glaucoma, Federal University of São Paulo, São Paulo, Brazil
  • Thais Tanno
    Glaucoma, Federal University of São Paulo, São Paulo, Brazil
  • Luiz Alberto Melo
    Glaucoma, Federal University of São Paulo, São Paulo, Brazil
  • Ivan Tavares
    Glaucoma, Federal University of São Paulo, São Paulo, Brazil
  • Christiane Rolim de Moura
    Glaucoma, Federal University of São Paulo, São Paulo, Brazil
  • Footnotes
    Commercial Relationships Bruno Esporcatte, None; Camila Netto, None; Thais Tanno, None; Luiz Alberto Melo, None; Ivan Tavares, None; Christiane Rolim de Moura, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4487. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Bruno Esporcatte, Camila Netto, Thais Tanno, Luiz Alberto Melo, Ivan Tavares, Christiane Rolim de Moura; Ahmed glaucoma valve FP7 and FP8 in pediatric glaucoma: A randomized clinical trial. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4487. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To compare the results of two models of Ahmed Glaucoma Valve (AGV) (New World Medical, Rancho Cucamonga, CA) implants (FP7 and FP8) in patients with pediatric glaucoma.

 
Methods
 

A prospective, randomized, clinical trial was carried out. Patients with primary or secondary pediatric glaucoma who previously underwent anti-glaucoma surgery were enrolled. The patients were randomly allocated to receive either FP7 or FP8 AGV model and were examined under general anesthesia just before and 6 months after glaucoma implant surgery.

 
Results
 

A total of 8 patients (8 eyes) received FP7 implants and 7 patients (7 eyes) received FP8 implants. The mean (standard deviaton) age of the FP7 and FP8 groups was 4.9 (3.8) years and 4.7 (2.9) years, respectively. No statistically significance differences in intraocular pressure, axial length, corneal diameter and limbus-plate distance were found between groups at the 6-month postoperative visit (p>0.05, Table).

 
Conclusions
 

There is no significant difference in the 6-month follow-up of anti-glaucoma surgery using FP7 and FP8 AGV model in pediatric glaucoma.

  
Keywords: 757 visual development: infancy and childhood • 466 clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×